Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
Condition(s):Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:June 11, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:June 11, 2010Completed
Condition(s):LymphomaLast Updated:January 16, 2013Completed
Condition(s):LeukemiaLast Updated:February 4, 2013Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:June 22, 2023Completed
Condition(s):B-Cell Prolymphocytic Leukemia; Hypodiploidy; Loss of Chromosome 17p; Plasma Cell Leukemia; Progression of Multiple Myeloma or Plasma Cell Leukemia; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Non-Hodgkin Lymphoma; Refractory Plasma Cell Myeloma; Refractory Small Lymphocytic Lymphoma; t(14;16); t(4;14); T-Cell Prolymphocytic Leukemia; Waldenstrom MacroglobulinemiaLast Updated:June 11, 2019Completed
Condition(s):Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Last Updated:April 4, 2023Completed
Condition(s):Refractory Plasma Cell MyelomaLast Updated:January 22, 2020Completed
Condition(s):CD20 Positive; Hematopoietic and Lymphoid Cell Neoplasm; Lymphocytic Neoplasm; LymphomaLast Updated:September 10, 2019Completed
Condition(s):Prolymphocytic Leukemia; Recurrent Adult Hodgkin Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; T-Cell Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic LeukemiaLast Updated:January 29, 2020Completed
Condition(s):Multiple MyelomaLast Updated:December 7, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.